Primary small bowel adenocarcinoma: current view on clinical features, risk and prognostic factors, treatment and outcome

References

• Halfdanarson TR, McWilliams RR, Donohue JH, et al. A single-institution experience with 491 cases of small bowel adenocarcinoma. Am J Surg. 2010;199:797–803.
   PubMed Web of Science ®Google Scholar
• Dabaja BS, Suki D, Pro B, et al. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer. 2004;101:518–526.
   PubMed Web of Science ®Google Scholar
• Ugurlu MM, Asoglu O, Potter DD, et al. Adenocarcinomas of the jejunum and ileum: a 25-year experience. J Gastrointest Surg. 2005;9:1182–1188.
   PubMed Web of Science ®Google Scholar
• Schwameis K, Schoppmann SF, Stift J, et al. Small bowel adenocarcinoma – terra incognita: a demand for cross-national pooling of data. Oncol Lett. 2014;7:1613–1617.
   PubMed Web of Science ®Google Scholar
• Schottenfeld D, Beebe-Dimmer JL, Vignea FD. The epidemiology and pathogenesis of neoplasia in the small intestine. Ann Epidemiol. 2009;19:58–69.
   PubMed Web of Science ®Google Scholar
• Bakaeen FG, Murr MM, Sarr MG, et al. What prognostic factors are important in duodenal adenocarcinoma? Arch Surg. 2000;135:635–641.
   PubMed Web of Science ®Google Scholar
• Pan SY, Morrison H. Epidemiology of cancer of the small intestine. World J Gastrointest Oncol. 2011;3:33–42.
   PubMed Web of Science ®Google Scholar
• Umman P, Adiyodi V, Narayan C. Small bowel adenocarcinoma – report of two cases and review of literature. Indian J Surg. 2013;75:123–127.
   PubMed Web of Science ®Google Scholar
• Reynolds I, Healy P, Mcnamara DA. Malignant tumours of the small intestine. Surgeon. 2014;12:263–270.
   PubMed Web of Science ®Google Scholar
• Guo X, Mao Z, Su D, et al. The clinical pathological features, diagnosis, treatment and prognosis of small intestine primary malignant tumors. Med Oncol. 2014;31:913.
   PubMed Web of Science ®Google Scholar
• Delaunoit T, Neczyporenko F, Limburg PJ, et al. Pathogenesis and risk factors of small bowel adenocarcinoma: a colorectal cancer sibling? Am J Gastroenterol. 2005;100:703–710.
   PubMed Web of Science ®Google Scholar
• Brücher M, Stein HJ, Roder JD, et al. New aspects of prognostic factors in adenocarcinomas of the small bowel. Hepatogastroenterology 2001;48:727–732.
   PubMedGoogle Scholar
• Howe JR, Karnell LH, Menck HR, et al. The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the National Cancer Data Base 1985–1995. Cancer. 1999;86:2693–2706.
   PubMed Web of Science ®Google Scholar
• Agrawal S, McCarron EC, Gibbs JF, et al. Surgical management and outcome in primary adenocarcinoma of the small bowel. Ann Surg Oncol. 2007;14:2263–2269.
   PubMed Web of Science ®Google Scholar
• Wu TJ, Yeh CN, Chao TC, et al. Prognostic factors of primary small bowel adenocarcinoma: univariate and multivariate analysis. World J Surg. 2006;30:391–398.
   PubMed Web of Science ®Google Scholar
• Ito H, Perez A, Brooks D, et al. Surgical treatment of small bowel cancer: a 20-year single institution experience. J Gastrointest Surg. 2003;7:925–930.
   PubMed Web of Science ®Google Scholar
• Chaiyasate K, Jain AK, Cheung LY, et al. Prognostic factors in primary adenocarcinoma of the small intestine: 13-year single institution experience. World J Surg Oncol. 2008;6:12.
   PubMed Web of Science ®Google Scholar
• Zouhairi ME, Venner A, Charabaty A, et al. Small bowel adenocarcinoma. Curr Treat Options Oncol. 2008;9:388–399.
   PubMed Web of Science ®Google Scholar
• Neely D, Ong J, Patterson J, et al. Small intestinal adenocarcinoma: rarely considered, often missed? Postgrad Med J. 2013;89:197–201.
   PubMed Web of Science ®Google Scholar
• Overman MJ. Recent advances in the management of adenocarcinoma of the small intestine. Gastrointest Cancer Res. 2009;3:90–96.
   PubMedGoogle Scholar
• Chang HK, Yu E, Kim J, et al. Adenocarcinoma of the small intestine: a multi-institutional study of 197 surgically resected cases. Hum Pathol. 2010;41:1087–1096.
   PubMed Web of Science ®Google Scholar
• Faivre J, Trama A, De Angelis R, et al. Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002. Eur J Cancer. 2012;48:1417–1424.
   PubMed Web of Science ®Google Scholar
• Hong SH, Koh YH, Rho SY, et al. Primary adenocarcinoma of the small intestine: presentation, prognostic factors and clinical outcome. Jpn J Clin Oncol. 2009;39:54–61.
   PubMed Web of Science ®Google Scholar
• Aparicio T, Zaanan A, Svrcek M, et al. Small bowel adenocarcinoma: epidemiology, risk factors, diagnosis and treatment. Dig Liver Dis. 2014;46:97–104.
   PubMedGoogle Scholar
• Lepage C, Bouvier AM, Manfredi S, et al. Incidence and management of primary malignant small bowel cancers: a well-defined French population study. Am J Gastroenterol. 2006;101:2826–2832.
   PubMed Web of Science ®Google Scholar
• Goodman MT, Matsuno RK, Shvetsov YB. Racial and ethnic variation in the incidence of small-bowel cancer subtypes in the United States, 1995–2008. Dis Colon Rectum. 2013;56:441–448.
   PubMed Web of Science ®Google Scholar
• Laforest A, Aparicio T, Zaanan A, et al. ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma. Eur J Cancer. 2014;50:1740–1746.
   PubMed Web of Science ®Google Scholar
• Aparicio T, Svrcek M, Zaanan A, et al. Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study. Br J Cancer. 2013;109:3057–3066.
   PubMed Web of Science ®Google Scholar
• Alvi MA, McArt DG, Kelly P, et al. Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utility. Oncotarget 2015;6:20863–20874.
   PubMed Web of Science ®Google Scholar
• Schrock AB, Devoe CE, McWilliams R, et al. Genomic profiling of small bowel adenocarcinoma. JAMA Oncol. 2017. doi: 10.1001/jamaoncol.2017.1051. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• ASGE Standards of Practice Committee, Fisher L, Lee Krinsky M, et al. The role of endoscopy in the management of obscure GI bleeding. Gastrointest Endosc. 2010;72:471–479.
   PubMed Web of Science ®Google Scholar
• Eliakim R. Wireless capsule video endoscopy: three years of experience. World J Gastroenterol. 2004;10:1238–1239.
   PubMed Web of Science ®Google Scholar
• Hakim FA, Alexander JA, Huprich JE, et al. CT-enterography may identify small bowel tumors not detected by capsule endoscopy: eight years experience at Mayo Clinic Rochester. Dig Dis Sci. 2011;56:2914–2919.
   PubMed Web of Science ®Google Scholar
• Boudiaf M, Jaff A, Soyer P, et al. Small-bowel diseases: prospective evaluation of multi-detector row helical CT enteroclysis in 107 consecutive patients. Radiology 2004;233:338–344.
   PubMed Web of Science ®Google Scholar
• Pilleul F, Penigaud M, Milot L, et al. Possible small-bowel neoplasms: contrast-enhanced and water-enhanced multidetector CT enteroclysis. Radiology 2006;241:796–801.
   PubMed Web of Science ®Google Scholar
• Rondonotti E, Marmo R, Petracchini M, et al. The American Society of Gastrointestinal Endoscopy (ASGE) diagnostic algorithm for obscure gastrointestinal bleeding: Eight burning questions from everyday clinical practice. Dig Liver Dis. 2013;45:179–185.
   PubMedGoogle Scholar
• Masselli G, Polettini E, Casciani E, et al. Small-bowel neoplasms: prospective evaluation of MR enteroclysis. Radiology 2009;251:743–750.
   PubMed Web of Science ®Google Scholar
• Khalife S, Soyer P, Alatawi A, et al. Obscure gastrointestinal bleeding: preliminary comparison of 64-section CT enteroclysis with video capsule endoscopy. Eur Radiol. 2011;21:79–86.
   PubMed Web of Science ®Google Scholar
• Huprich JE, Fletcher JG, Fidler JL, et al. Prospective blinded comparison of wireless capsule endoscopy and multiphase CT enterography in obscure gastrointestinal bleeding. Radiology 2011;260:744–751.
   PubMed Web of Science ®Google Scholar
• Huprich JE, Fletcher JG, Alexander JA, et al. Obscure gastrointestinal bleeding: evaluation with 64-section multiphase CT enterography-initial experience. Radiology 2008;246:562–571.
   PubMed Web of Science ®Google Scholar
• Singhal N, Singhal D. Adjuvant chemotherapy for small intestine adenocarcinoma. Cochrane Database Syst Rev. 2007;3:CD005202.
   Web of Science ®Google Scholar
• Young JI, Mongoue-Tchokote S, Wieghard N, et al. Treatment and survival of small-bowel adenocarcinoma in the United States: a comparison with colon cancer. Dis Colon Rectum. 2016;59:306–315.
   PubMed Web of Science ®Google Scholar
• Bilimoria KY, Bentrem DJ, Wayne JD, et al. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg. 2009;249:63–71.
   PubMed Web of Science ®Google Scholar
• Overman MJ, Kopetz S, Lin E, et al. Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine. Acta Oncol. 2010;49:474–479.
   PubMed Web of Science ®Google Scholar
• Ecker L, McMillan MT, Datta J, et al. Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: a propensity score-matched analysis. Cancer 2016;122:693–701.
   PubMed Web of Science ®Google Scholar
• Gibson MK, Holcroft CA, Kvols LK, et al. Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma. Oncologist 2005;10:132–137.
   PubMed Web of Science ®Google Scholar
• Overman MJ, Varadhachary GR, Kopetz S, et al. Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater. J Clin Oncol. 2009;27:2598–2603.
   PubMed Web of Science ®Google Scholar
• Czaykowski P, Hui D. Chemotherapy in small bowel adenocarcinoma: 10-year experience of the British Columbia Cancer Agency. Clin Oncol (R Coll Radiol). 2007;19:143–149.
   PubMed Web of Science ®Google Scholar
• Fishman PN, Pond GR, Moore MJ, et al. Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: a retrospective review of 113 cases. Am J Clin Oncol. 2006;29:225–231.
   PubMed Web of Science ®Google Scholar
• Locher C, Malka D, Boige V, et al. Combination chemotherapy in advanced small bowel adenocarcinoma. Oncology 2005;69:290–294.
   PubMed Web of Science ®Google Scholar
• Tsushima T, Taguri M, Honma Y, et al. Multicenter retrospective study of 132 patients with unresectable small bowel adenocarcinoma treated with chemotherapy. Oncologist 2012;17:1163–1170.
   PubMed Web of Science ®Google Scholar
• Xiang XJ, Liu YW, Zhang L, et al. A phase II study of modified FOLFOX as first-line chemotherapy in advanced small bowel adenocarcinoma. Anticancer Drugs. 2012;23:561–566.
   PubMed Web of Science ®Google Scholar
• Overman MJ, Kopetz S, Wen S, et al. Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma. Cancer 2008;113:2038–2045.
   PubMed Web of Science ®Google Scholar
• Zaanan A, Costes L, Gauthier M, et al. Chemotherapy of advanced small-bowel adenocarcinoma: a multicenter AGEO study. Ann Oncol. 2010;21:1786–1793.
   PubMed Web of Science ®Google Scholar
• Zaanan A, Gauthier M, Malka D, et al. Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy: a multicenter AGEO study. Cancer 2011;117:1422–1428.
   PubMed Web of Science ®Google Scholar
• Jacks SP, Hundley JC, Shen P, et al. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma. J Surg Oncol. 2005;91:112–117.
   PubMed Web of Science ®Google Scholar
• Sun Y, Shen P, Stewart JH, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma. Am Surg. 2013;79:644–648.
   PubMed Web of Science ®Google Scholar
• Liu Y, Ishibashi H, Takeshita K, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal dissemination from small bowel malignancy: result from single specialized center. Ann Surg Oncol. 2016;23:1625–1631.
   PubMed Web of Science ®Google Scholar
• Tsang H, Yau T, Khong PL, et al. Bevacizumab-based therapy for advanced small bowel adenocarcinoma. Gut 2008;57:1631–1632.
   PubMed Web of Science ®Google Scholar
• Aydin D, Sendur MA, Kefeli U, et al. Evaluation of bevacizumab in advanced small bowel adenocarcinoma. Clin Colorectal Cancer 2016; 16:78–83.
   Web of Science ®Google Scholar
• Blaker H, Helmchen B, Bonisch A, et al. Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas. Scand J Gastroenterol. 2004;39:748–753.
   PubMed Web of Science ®Google Scholar
• Zaaimi Y, Aparicio T, Laurent-Puig P, et al. Advanced small bowel adenocarcinoma: molecular characteristics and therapeutic perspectives. Clin Res Hepatol Gastroenterol. 2016;40:154–160.
   PubMed Web of Science ®Google Scholar
• Nicholl MB, Ahuja V, Conway WC, et al. Small bowel adenocarcinoma: understaged and undertreated? Ann Surg Oncol. 2010;17:2728–2732.
   PubMed Web of Science ®Google Scholar